Alpha One

Founder of Alpha Briefing, a high-signal intelligence and finance platform delivering sharp analysis at the intersection of markets, geopolitics, and strategy.

Members only

Space Featured

Why AI Compute Is Pushing Toward Orbit

AI is becoming an electricity problem. Some firms are now exploring space-based data centers powered by solar energy. If compute moves off-planet, the winners may not be who you think. We outline six public companies positioned across the AI space infrastructure stack.

Paid-members only

Iran Featured

🌍 The 96-Hour Window: If the U.S. and Israel Hit Iran, What Breaks First — and What Trades First

If the U.S. and Israel strike Iran, markets won’t wait for headlines. Oil, defense, cyber, and shipping could move within hours. We break down the 96-hour war scenario, regime-change odds, and the stocks positioned to react first.

Paid-members only

Greenland

Davos Just Became a Geopolitical Trade Signal

Davos wasn’t theater. Trump framed Greenland as a U.S. national security requirement, not a diplomatic curiosity. Markets heard politics. They should have heard doctrine — and the quiet repricing now underway across defense, space, and Europe.

Paid-members only

AlphaBriefing Watchlist: U.S. Stocks to Watch for the Remainder of January

January reveals who’s positioned and who’s guessing. This AlphaBriefing watchlist identifies U.S. stocks tied to AI, cloud, healthcare, and real capital flows—designed for investors who prefer signal over noise.

Members only

Greenland Featured

America Needs Greenland. These U.S. Companies Are Ready.

Greenland isn’t about headlines—it’s about leverage. From Arctic security to critical minerals and future trade routes, U.S. control would quietly reshape global power. This AlphaBriefing breaks down which American companies are positioned to support that shift over the next 3–5 years.

Members only

Biotech Featured

👁️ Outlook Therapeutics Eyes FDA Approval of Wet AMD Drug as Investors Bet on Upside

Outlook Therapeutics ($OTLK) is approaching a critical FDA decision this month for its wet AMD drug Lytenava. Approval could unlock a large market and reprice the stock sharply higher, while failure keeps risk elevated. This is a highstakes biotech moment investors are watching closely.

Paid-members only

Premium Briefing Featured

The Quiet December Trade 🎯

December isn’t bullish or bearish—it’s operational. While most investors debate the “Santa rally,” large allocators manage optics, liquidity, and taxes. That disconnect creates distorted prices, forced selling, and setups many only recognize after January.

Conflict Featured

⚠️ 🇨🇳 🇹🇼 The 2027 Cross‑Strait Showdown: China, Taiwan, and the Next Global Shockwave

A potential China–Taiwan conflict in 2027 could reshape global markets. This in-depth guide breaks down the risks, historical parallels, and sectors to watch — from defense to semiconductors — and shows how investors can prepare before the world catches up.

Paid-members only

Rare Earths Featured

🔬 AlphaBriefing™ Special Report: Top 10 U.S. Rare Earth Stocks for 2025–2030

America is rebuilding its entire rare-earth supply chain—from mines to magnets. We break down the companies best positioned to win as the U.S. pours billions into critical minerals and national-security metals.

Paid-members only

Space Featured

🛸 AlphaBriefing Red Team Special Edition - The Age of Disclosure: If the President Confirms Aliens, Here’s What the Market Actually Does

If the President announces Disclosure, markets won’t react the way Hollywood thinks they will. Some areas surge, others seize up instantly. We break down the first moves smart money makes—before the rest of the world catches on.

Members only

Cyber Featured

⛈️ The Cyber Storm of 2025: How Anthropic Stopped the First Reported AI-Run Espionage Campaign — And Why It Matters

Anthropic uncovered the first reported large-scale cyberattack run mostly by an autonomous artificial intelligence system. We break down what happened, why it matters, and what everyday people and businesses must do now.

Paid-members only

Premium Briefing Featured

🦃 Turkey, Traffic, and Trading: The Weird Market Rhythm of Thanksgiving Week

Thanksgiving week creates one of the strangest rhythms in the market—slow volume, wild sentiment, and a surge in online spending. Here’s how retail, e-commerce, travel, and payments tend to move from Black Friday into Cyber Monday.

Paid-members only

Premium Briefing Featured

🚨 AlphaBriefing Operational Brief — Week of November 17–22, 2025

This week, markets collide with three forces at once: NVIDIA’s pivotal AI earnings, a dangerous China–Japan escalation over Taiwan, and the high-impact debut of The Age of Disclosure. Here’s the intelligence investors need before the week begins.

Members only

Free Premium Briefing Featured

🏛️ Shutdown, Showdown, and the Markets: How Washington Chaos Is Quietly Repricing Risk

Day 40 of the shutdown is quietly reshaping the market. Yields stay elevated, data is frozen, and money is rotating into defense, utilities, energy, and gold. Airlines enter a high-stakes window before Thanksgiving. Here’s how to position for the week ahead.

Paid-members only

Artificial Intelligence Featured

🧠 The New Arms Race: How AI Became the World’s Ultimate Power Weapon

AI is the new arms race. The U.S., China, Russia, and the EU are pouring billions into AI, chips, and autonomous systems. This isn’t science fiction — it’s the next phase of power politics, markets, and security.

Paid-members only

Premium Briefing Featured

🎃 AlphaBriefing: Morning Intel — The Calm Before the Catalyst ⚡

🎃 Markets are calm—but don’t be fooled. The ghosts of over-valuation still haunt tech. Our Halloween Intel Brief reveals where the smart money’s hiding and which 5 stocks could light your lantern through November.

Paid-members only

Nuclear Featured

🇺🇸⚡ America’s Nuclear Renaissance: 10 Stocks Ready to Explode

The U.S. just committed at least $80B to new nuclear reactors. AI/data-centers and the Pentagon are driving demand. Here are the 10 stocks best positioned to profit — plus 5 bonus speculative plays.

Paid-members only

Premium Briefing Featured

Five Forces Squeezing Markets Right Now

A grinding U.S. shutdown, Europe’s phased ban on Russian liquefied natural gas, new U.S. sanctions on Russia’s top oil firms, a firmer uranium price, wider export-control talk reaching software, and AI’s hardware-anchored funding all tug markets at once—shifting cash flows, risk, and timelines.

Paid-members only

Premium Briefing

🌍 From Russia to China: Why Today’s Geopolitics Are Rattling Markets

Sanctions on Russian oil, proposed U.S.–China software export curbs, and weak prints from Tesla and IBM are shaking risk appetite. Inflation risk is back on the table, and volatility is the name of the game.

Paid-members only

Operational Brief Featured

⚔️ AlphaBriefing Operational Brief: Markets & Geopolitics in the Fog

Shutdown Day 20, oil chokepoints, PMIs, Big Tech earnings, rare earth tensions, and the AI race shape the week ahead. AlphaBriefing maps the risks, signals, and market themes every investor should have on radar.

Paid-members only

Rare Earths Featured

🌍 Rare Earth Reckoning: China’s Silent Stranglehold — and the Stocks Poised to Benefit

China is weaponizing rare earths — the metals behind EVs, missiles, and chips. As Beijing tightens export controls, the West scrambles to respond. Who wins this strategic minerals war? AlphaBriefing breaks it down — and shows you how to trade it.

Free Premium Briefing

🚀 Orbital Choke Points: The Coming Battle for Space-Based Data Centers

The Panama Canal once decided who ruled the seas. Now, new choke points orbit above us. Satellites are evolving into space-based data centers—and whoever controls these orbital lanes could control the flow of global information.

Paid-members only

Operational Brief Featured

🔥 Ceasefire & Shutdowns: Markets in the Fog

Markets face a foggy week: the shutdown delays key data, bank earnings set the tone, and a fragile Middle East ceasefire shifts risk. With OPEX Friday ahead, volatility looms—stay nimble, watch banks, oil, and the Fed’s Beige Book for direction

Members only

Artificial Intelligence Featured

⚙️ The 6-Gigawatt Shock: OpenAI’s AMD Deal Is Rewiring the AI Trade — Here’s How to Position by Monday

OpenAI just signed a 6-gigawatt chip deal with AMD — a move that could finally challenge Nvidia’s dominance. Here’s what it means for AI stocks you can buy today.

Paid-members only

Drones Featured

🚁 The Drone Arms Race: How UAV Warfare Is Reshaping Defense Investing

Drones are rewriting the battlefield — and the budget. The winners? Not just UAV makers, but also the firms building the lasers and jammers to destroy them. We break down the portfolio.